Institutional Ownership Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX). We have compiled data on the 315 institutions that hold shares in the stock, with a total of 202 Million shares, which have been reported (via 13F filing form) to have a value of $1.69 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
20,544,248
shares
|
$172 Million
0.0% of portfolio
|
Q2 2025
Reduced 5.15%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
19,956,255
shares
|
$167 Million
0.0% of portfolio
|
Q2 2024
Added 8.22%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
8,505,392
shares
|
$71 Million
0.0% of portfolio
|
Q2 2025
Added 8.86%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
8,463,742
shares
|
$70.7 Million
9.06% of portfolio
|
Q2 2025
Reduced 5.21%
|
|
|
Alkeon Capital Management LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
5,714,021
shares
|
$47.7 Million
0.09% of portfolio
|
Q2 2025
Reduced 20.79%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
5,614,651
shares
|
$46.9 Million
0.01% of portfolio
|
Q2 2025
Added 133.63%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
5,329,679
shares
|
$44.5 Million
0.0% of portfolio
|
Q2 2025
Added 131.96%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
5,286,536
shares
|
$44.1 Million
0.04% of portfolio
|
Q2 2023
Reduced 5.91%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
5,054,610
shares
|
$42.2 Million
0.0% of portfolio
|
Q2 2025
Added 1.89%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Aug 14, 2025 Q2 2025 |
4,692,000
shares
|
$39.2 Million
0.97% of portfolio
|
Q2 2025
Reduced 9.59%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
4,500,000
shares
|
$37.6 Million
0.74% of portfolio
|
Q2 2025
Reduced 48.28%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
4,389,477
shares
|
$36.7 Million
0.03% of portfolio
|
Q2 2025
Added 176.22%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
4,288,223
shares
|
$35.8 Million
0.08% of portfolio
|
Q2 2025
Added 109.64%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Aug 13, 2025 Q2 2025 |
4,278,555
shares
|
$35.7 Million
0.03% of portfolio
|
Q2 2025
Added 2103.71%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
4,228,412
shares
|
$35.3 Million
0.08% of portfolio
|
Q2 2025
Added 31.29%
|
|
|
Assenagon Asset Management S.A.
|
Jul 11, 2025 Q2 2025 |
3,620,637
shares
|
$30.2 Million
0.05% of portfolio
|
Q2 2025
Added 25631.2%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
3,534,454
shares
|
$29.5 Million
0.01% of portfolio
|
Q2 2025
Added 148.27%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
3,523,917
shares
|
$29.4 Million
0.0% of portfolio
|
Q2 2025
Added 82.4%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,419,046
shares
|
$28.5 Million
0.01% of portfolio
|
Q4 2024
Reduced 28.99%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
2,841,155
shares
|
$23.7 Million
0.0% of portfolio
|
Q2 2025
Added 97.9%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Aug 13, 2025 Q2 2025 |
2,782,489
shares
|
$23.2 Million
0.01% of portfolio
|
Q2 2025
Reduced 8.83%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Aug 11, 2025 Q2 2025 |
2,623,537
shares
|
$21.9 Million
0.21% of portfolio
|
Q2 2025
Reduced 9.05%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
2,557,432
shares
|
$21.4 Million
0.0% of portfolio
|
Q2 2025
Added 345.4%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
2,526,734
shares
|
$21.1 Million
0.03% of portfolio
|
Q2 2025
Added 317.49%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Aug 14, 2025 Q2 2025 |
2,474,075
shares
|
$20.7 Million
0.09% of portfolio
|
Q2 2025
Added 21.65%
|